TRPV4 and neuromuscular disease: Together, these results suggest that reduced interaction of neuromuscular disease-causing TRPV4 mutants with ARHGEF10 and the resulting loss of ARHGEF10-mediated inhibition may contribute to the increased ion channel activity characteristic of these mutant channels.